U.S. Formulation Development Outsourcing Market (2025 - 2030) Size, Share, & Trends Analysis Report By Service, By Formulation (Oral, Injectable), By Therapeutic Area (Oncology), By End Use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                         1.2.1. Service
                         1.2.2. Formulation
                         1.2.3. Therapeutic Area
                         1.2.4. End Use
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                         1.5.1. Purchased Database
                         1.5.2. GVR’s Internal Database
                         1.5.3. Secondary Sources
                         1.5.4. Primary Research
                    1.6. Information Analysis
                         1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                         1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Formulation Development Outsourcing Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                         3.2.1. Market Driver Analysis
                         3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                         3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                              3.3.1.1. Supplier Power
                              3.3.1.2. Buyer Power
                              3.3.1.3. Substitution Threat
                              3.3.1.4. Threat of New Entrants
                              3.3.1.5. Competitive Rivalry
                         3.3.2. PESTLE Analysis
Chapter 4. U.S. Formulation Development Outsourcing Market: Service Business Analysis
                    4.1. Service Market Share, 2024 & 2030
                    4.2. Service Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
                    4.4. Pre-formulation
                         4.4.1. Pre-formulation Market, 2018 - 2030 (USD Million)
                    4.5. Formulation Development
                         4.5.1. Formulation Development Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Formulation Development Outsourcing Market: Formulation Business Analysis
                    5.1. Formulation Market Share, 2024 & 2030
                    5.2. Formulation Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
                    5.4. Oral
                         5.4.1. Oral Formulation Market, 2018 - 2030 (USD Million)
                    5.5. Injectable
                         5.5.1. Injectable Formulation Market, 2018 - 2030 (USD Million)
                    5.6. Topical
                         5.6.1. Topical Formulation Market, 2018 - 2030 (USD Million)
                    5.7. Others
                         5.7.1. Other Formulation Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Therapeutic Area Development Outsourcing Market: Therapeutic Area Business Analysis
                    6.1. Therapeutic Area Market Share, 2024 & 2030
                    6.2. Therapeutic Area Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
                    6.4. Oncology
                         6.4.1. Formulation Development Outsourcing Market, for Oncology, 2018 - 2030 (USD Million)
                    6.5. Infectious Disease
                         6.5.1. Formulation Development Outsourcing Market, for Infectious Disease, 2018 - 2030 (USD Million)
                    6.6. Neurology
                         6.6.1. Formulation Development Outsourcing Market, for Neurology, 2018 - 2030 (USD Million)
                    6.7. Hematology
                         6.7.1. Formulation Development Outsourcing Market, for Hematology, 2018 - 2030 (USD Million)
                    6.8. Respiratory
                         6.8.1. Formulation Development Outsourcing Market, for Respiratory, 2018 - 2030 (USD Million)
                    6.9. Cardiovascular
                         6.9.1. Formulation Development Outsourcing Market, for Cardiovascular, 2018 - 2030 (USD Million)
                    6.10. Dermatology
                         6.10.1. Formulation Development Outsourcing Market, for Dermatology, 2018 - 2030 (USD Million)
                    6.11. Others
                         6.11.1. Formulation Development Outsourcing Market, for Others, 2018 - 2030 (USD Million)
Chapter 7. U.S. Formulation Development Outsourcing Market: End Use Business Analysis
                    7.1. End Use Market Share, 2024 & 2030
                    7.2. End Use Segment Dashboard
                    7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    7.4. Pharmaceutical and Biopharmaceutical Companies
                         7.4.1. Pharmaceutical and Biopharmaceutical Companies Segment Market, 2018 - 2030 (USD Million)
                    7.5. Government and Academic Institutes
                         7.5.1. Government and Academic Institutes Segment Market, 2018 - 2030 (USD Million)
                    7.6. Others
                         7.6.1. Others Segment Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Participant Overview
                    8.2. Company Market Position Analysis
                    8.3. Company Categorization
                    8.4. Strategy Mapping
                    8.5. Company Profiles/Listing
                         8.5.1. SGS Société Générale de Surveillance SA
                              8.5.1.1. Overview
                              8.5.1.2. Financial Performance
                              8.5.1.3. Product Benchmarking
                              8.5.1.4. Strategic Initiatives
                         8.5.2. Intertek Group plc
                              8.5.2.1. Overview
                              8.5.2.2. Financial Performance
                              8.5.2.3. Product Benchmarking
                              8.5.2.4. Strategic Initiatives
                         8.5.3. Recipharm AB
                              8.5.3.1. Overview
                              8.5.3.2. Financial Performance
                              8.5.3.3. Product Benchmarking
                              8.5.3.4. Strategic Initiatives
                         8.5.4. Lonza
                              8.5.4.1. Overview
                              8.5.4.2. Financial Performance
                              8.5.4.3. Product Benchmarking
                              8.5.4.4. Strategic Initiatives
                         8.5.5. Charles River Laboratories
                              8.5.5.1. Overview
                              8.5.5.2. Financial Performance
                              8.5.5.3. Product Benchmarking
                              8.5.5.4. Strategic Initiatives
                         8.5.6. Eurofins Scientific
                              8.5.6.1. Overview
                              8.5.6.2. Financial Performance
                              8.5.6.3. Product Benchmarking
                              8.5.6.4. Strategic Initiatives
                         8.5.7. Element
                              8.5.7.1. Overview
                              8.5.7.2. Financial Performance
                              8.5.7.3. Product Benchmarking
                              8.5.7.4. Strategic Initiatives
                         8.5.8. Labcorp
                              8.5.8.1. Overview
                              8.5.8.2. Financial Performance
                              8.5.8.3. Product Benchmarking
                              8.5.8.4. Strategic Initiatives
                         8.5.9. Thermo Fisher Scientific Inc
                              8.5.9.1. Overview
                              8.5.9.2. Financial Performance
                              8.5.9.3. Product Benchmarking
                              8.5.9.4. Strategic Initiatives
                         8.5.10. Catalent, Inc
                              8.5.10.1. Overview
                              8.5.10.2. Financial Performance
                              8.5.10.3. Product Benchmarking
                              8.5.10.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. formulation development outsourcing market, by service, 2018 - 2030 (USD Million)
Table 4. U.S. formulation development outsourcing market, by formulation, 2018 - 2030 (USD Million)
Table 5. U.S. formulation development outsourcing market, by therapeutic area, 2018 - 2030 (USD Million)
Table 6. U.S. formulation development outsourcing market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. formulation development outsourcing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Service outlook (USD Million)
Fig. 10 Formulation outlook (USD Million)
Fig. 11 Therapeutic area outlook (USD Million)
Fig. 12 End use outlook (USD Million)
Fig. 13 Competitive landscape
Fig. 14 U.S. formulation development outsourcing market dynamics
Fig. 15 U.S. formulation development outsourcing market: Porter’s five forces analysis
Fig. 16 U.S. formulation development outsourcing market: Pestle analysis
Fig. 17 U.S. formulation development outsourcing market: Service segment dashboard
Fig. 18 U.S. formulation development outsourcing market: Service market share analysis, 2024 & 2030
Fig. 19 Pre-formulation market, 2018 - 2030 (USD Million)
Fig. 20 Formulation development market, 2018 - 2030 (USD Million)
Fig. 21 U.S. formulation development outsourcing market: Formulation segment dashboard
Fig. 22 U.S. formulation development outsourcing market: Formulation market share analysis, 2024 & 2030
Fig. 23 Oral formulation market, 2018 - 2030 (USD Million)
Fig. 24 Injectable formulation market, 2018 - 2030 (USD Million)
Fig. 25 Topical formulation market, 2018 - 2030 (USD Million)
Fig. 26 Other formulation market, 2018 - 2030 (USD Million)
Fig. 27 U.S. formulation development outsourcing market: Therapeutic area segment dashboard
Fig. 28 U.S. formulation development outsourcing market: Therapeutic area market share analysis, 2024 & 2030
Fig. 29 Formulation development outsourcing market, for Oncology, 2018 - 2030 (USD Million)
Fig. 30 Formulation development outsourcing market, for Infectious Disease, 2018 - 2030 (USD Million)
Fig. 31 Formulation development outsourcing market, for Neurology 2018 - 2030 (USD Million)
Fig. 32 Formulation development outsourcing market, for Hematology, 2018 - 2030 (USD Million)
Fig. 33 Formulation development outsourcing market, for Respiratory, 2018 - 2030 (USD Million)
Fig. 34 Formulation development outsourcing market, for Cardiovascular 2018 - 2030 (USD Million)
Fig. 35 Formulation development outsourcing market, for Dermatology, 2018 - 2030 (USD Million)
Fig. 36 Formulation development outsourcing market, for Others, 2018 - 2030 (USD Million)
Fig. 37 U.S. formulation development outsourcing market: End use segment dashboard
Fig. 38 U.S. formulation development outsourcing market: End use market share analysis, 2024 & 2030
Fig. 39 Pharmaceutical and biopharmaceutical companies segment market, 2018 - 2030 (USD Million)
Fig. 40 Government and academic institutes segment market, 2018 - 2030 (USD Million)
Fig. 41 Other segments market, 2018 - 2030 (USD Million)
Fig. 42 Company categorization
Fig. 43 Company market position analysis
Fig. 44 Strategic framework